サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Blood Screening Market - Global Forecasts to 2021

血液検査市場‐2021年までの世界予測

レポート概要

血液検査市場、方法別(核酸増幅、(rPCR)、ELISA、(CLIA、蛍光アッセイ)、迅速検査、NGS、ウェスタンブロッティング)、製品別(機器、試薬&キット、ソフトウェア)、エンドユーザー別(血液バンク、病院)‐2021年までの世界予測

世界の血液検査市場は2016年の17億6,000万ドルから2021年までには28億ドルに達し、この間のCAGRは9.7%と予想されます。世界の血液検査市場は大まかに方法別、製品&サービス別、エンドユーザー別、地域別に分類されます。方法別には、NAT、ELISA,迅速検査、ウェスタンブロットアッセイ、NGSが含まれます。NATのセグメントはさらに転写増幅法(TMA)とリアルタイムPCRに分けられます。ELISAのセグメントはさらに様々なプラットフォームや世代別に分類されます。ELISAはプラットフォーム別に化学ルミネセンス免疫検定(CLIA)、蛍光免疫測定法(FIA)、比色測定法(CL)に分類されます。世代別には、第1世代ELISA、第2世代ELISA、第3世代ELISA、第4世代以降ELISAに分けられます。

製品、サービス別では試薬&キット、機器、ソフトウェア&サービスに分類されます。試薬&キットのセグメントにはさらにNAT試薬&キット、ELISA試薬&キット、その他の試薬&キットが含まれます。機器市場は購入方法別に、レンタル購入と買い切り購入に分けられます。血液検査のエンドユーザー別には血液バンクと病院に分けられます。

この市場における主要プレイヤー:Grifols(スペイン)、Bio-Rad Laboratories, Inc.(米)、Roche Diagnostics(スイス)、bioMérieux (仏)、Abbott Laboratories(米)、Siemens Healthineers (独)、Thermo Fisher Scientific, Inc. (米)、Beckman Coulter, Inc. (米)、Ortho Clinical Diagnostics, Inc. (米)、Becton, Dickinson and Company(米)

レポート詳細

目次

Table of Contents

1 Introduction (Page No. - 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. - 17)
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown & Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary (Page No. - 24)
3.1 Introduction
3.2 Current Scenario
3.3 Conclusion

4 Premium Insights (Page No. - 29)
4.1 Blood Screening Market
4.2 Blood Screening Market, By Region & Technology

5 Market Overview (Page No. - 31)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Number of Blood Donations and Blood Donors
5.2.1.2 Increasing Demand of Donated Blood
5.2.1.3 Rising Prevalence of Infectious Diseases
5.2.1.4 Growing Affordability and Adoption of NAT for Blood Screening
5.2.1.5 Rising Awareness Regarding the Safety of Donated Blood
5.2.2 Restraints
5.2.2.1 Capital Expenditure and Operating Costs of NAT
5.2.2.2 Lack of Regulations Mandating the Use of NAT in Developing Countries
5.2.2.3 Emergence of Alternative Technologies
5.2.3 Opportunities
5.2.3.1 Pathogen Reduction Technology
5.2.3.2 Multiplex Tests
5.2.3.3 Emerging Economies
5.2.4 Challenges
5.2.4.1 Price Reduction

6 Blood Screening Market, By Technology (Page No. - 38)
6.1 Introduction
6.2 Blood Screening Market, By Volume (Number of Tests Conducted)
6.3 Nucleic Acid Test (NAT)
6.3.1 Transcription-Mediated Amplification (TMA)
6.3.2 Real-Time Polymerase Chain Reaction (PCR)
6.4 Enzyme-Linked Immunosorbent Assay (ELISA)
6.4.1 ELISA Market, By Platform
6.4.1.1 Chemiluminescence Immunoassay (CLIA)
6.4.1.2 Fluorescence Immunoassay (FIA)
6.4.1.3 Colorimetric Immunoassay (CI)
6.4.2 ELISA Market, By Generation
6.4.2.1 First-Generation ELISA
6.4.2.2 Second-Generation ELISA
6.4.2.3 Third-Generation ELISA
6.4.2.4 Fourth-Generation & Above
6.5 Rapid Tests
6.6 Western Blot Assay
6.7 Next-Generation Sequencing (NGS)

7 Blood Screening Market, By Product and Service (Page No. - 56)
7.1 Introduction
7.2 Reagents & Kits
7.2.1 NAT Reagents & Kits
7.2.1.1 Enzymes and Polymerases
7.2.1.2 Standards and Controls
7.2.1.3 Probes and Primers
7.2.1.4 Buffers, Nucleotides and Solutions
7.2.1.5 Labeling and Detection Reagents
7.2.2 ELISA Reagents & Kits
7.2.2.1 Immunosorbents
7.2.2.2 Controls
7.2.2.3 Conjugates (Antigen Or Antibody-Conjugated Enzyme)
7.2.2.4 Substrates (Of Enzymes)
7.2.2.5 Sample Diluents and Wash Solutions
7.2.3 Other Reagents
7.3 Instruments
7.3.1 Rental Purchase
7.3.2 Outright Purchase
7.4 Software and Services

8 Blood Screening Market, By End User (Page No. - 68)
8.1 Introduction
8.2 Blood Banks
8.3 Hospitals

9 Blood Screening Market, By Region (Page No. - 72)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe (RoE)
9.4 Asia
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia (RoA)
9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. - 104)
10.1 Overview
10.2 Market Share Analysis
10.2.1 Market Share Analysis for NAT
10.2.2 Blood Screening Market Share Analysis
10.3 Competitive Situations and Trends
10.3.1 Product Launches
10.3.2 Regulatory Approvals
10.3.3 Agreements
10.3.4 Partnerships
10.3.5 Acquisitions
10.3.6 Expansions

11 Company Profiles (Page No. - 113)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Introduction
11.2 Grifols
11.3 F. Hoffmann-La Roche
11.4 Abbott Laboratories
11.5 Biomérieux
11.6 Bio-Rad Laboratories, Inc.
11.7 Siemens Healthineers (A Subsidiary of Siemens AG)
11.8 Ortho Clinical Diagnostics, Inc.
11.9 Thermo Fisher Scientific, Inc.
11.10 Beckman Coulter (A Subsidiary of Danaher Corporation)
11.11 Becton, Dickinson and Company

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 139)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details

List of Tables (97 Tables)
Table 1 Blood Screening Market Size, By Technology, 2014-2021 (USD Million)
Table 2 Global Market, By Volume (Number of Tests), 2015
Table 3 North America: Market, By Volume (Number of Tests), 2015
Table 4 Europe: Market, By Volume (Number of Tests), 2015
Table 5 Asia: Market, By Volume (Number of Tests), 2015
Table 6 Market Size for NAT, By Country, 2014-2021 (USD Million)
Table 7 Market Size for NAT, By Type, 2014-2021 (USD Million)
Table 8 TMA Market Size, By Country, 2014-2021 (USD Million)
Table 9 Real-Time PCR Market Size, By Country, 2014-2021 (USD Million)
Table 10 Market Size for ELISA, By Country, 2014-2021 (USD Million)
Table 11 Market Size for ELISA, By Platform, 2014-2021 (USD Million)
Table 12 CLIA Market Size, By Country, 2014-2021 (USD Million)
Table 13 FIA Market Size, By Country, 2014-2021 (USD Million)
Table 14 CI Market Size, By Country, 2014-2021 (USD Million)
Table 15 Market Size for ELISA, By Generation, 2014-2021 (USD Million)
Table 16 First-Generation ELISA Market Size, By Country, 2014-2021 (USD Million)
Table 17 Second-Generation ELISA Market Size, By Country, 2014-2021 (USD Million)
Table 18 Third-Generation ELISA Market Size, By Country, 2014-2021 (USD Million)
Table 19 Fourth-Generation ELISA Market Size, By Country, 2014-2021 (USD Million)
Table 20 Market Size for Rapid Tests, By Country, 2014-2021 (USD Million)
Table 21 Market Size for Western Blot Assay, By Country, 2014-2021 (USD Million)
Table 22 Market Size for NGS, By Country, 2014-2021 (USD Million)
Table 23 Market Size, By Product and Service, 2014-2021 (USD Million)
Table 24 Blood Screening Reagents and Kits Market Size, By Country, 2014-2021 (USD Million)
Table 25 Blood Screening Reagents and Kits Market Size, By Type, 2014-2021 (USD Million)
Table 26 NAT Reagents & Kits Market Size, By Country, 2014-2021 (USD Million)
Table 27 NAT Reagents & Kits Market Size, By Type, 2014-2021 (USD Million)
Table 28 ELISA Reagents & Kits Market Size, By Country, 2014-2021 (USD Million)
Table 29 ELISA Reagents & Kits Market Size, By Type, 2014-2021 (USD Million)
Table 30 Other Reagents & Kits Market Size, By Country, 2014-2021 (USD Million)
Table 31 Blood Screening Instruments Market Size, By Country, 2014-2021 (USD Million)
Table 32 Blood Screening Instruments Market Size, By Purchase Mode, 2014-2021 (USD Million)
Table 33 Rental Purchase Market Size, By Country, 2014-2021 (USD Million)
Table 34 Outright Purchase Market Size, By Country, 2014-2021 (USD Million)
Table 35 Blood Screening Software and Services Market Size, By Country, 2014-2021 (USD Million)
Table 36 Market Size, By End User, 2014-2021 (USD Million)
Table 37 Market Size for Blood Banks, By Country, 2014-2021 (USD Million)
Table 38 Market Size for Hospitals, By Country, 2014-2021 (USD Million)
Table 39 Global Market Size, By Region, 2012-2019 (USD Million)
Table 40 North America: Market Size, By Country, 2014-2021 (USD Million)
Table 41 North America: Market Size, By Technology, 2014-2021 (USD Million)
Table 42 North America: Market Size, By Product and Service, 2014-2021 (USD Million)
Table 43 North America: Market Size, By End User, 2014-2021 (USD Million)
Table 44 Number of Organ Transplantations Performed in the U.S., 2014-2015
Table 45 U.S.: Market Size, By Technology, 2014-2021 (USD Million)
Table 46 U.S.: Market Size, By Product and Service, 2014-2021 (USD Million)
Table 47 U.S.: Market Size, By End User, 2014-2021 (USD Million)
Table 48 Canada: Market Size, By Technology, 2014-2021 (USD Million)
Table 49 Canada: Market Size, By Product and Service, 2014-2021 (USD Million)
Table 50 Canada: Market Size, By End User, 2014-2021 (USD Million)
Table 51 Europe: Market Size, By Country, 2014-2021 (USD Million)
Table 52 Europe: Market Size, By Technology, 2014-2021 (USD Million)
Table 53 Europe: Market Size, By Product and Service, 2014-2021 (USD Million)
Table 54 Europe: Market Size, By End User, 2014-2021 (USD Million)
Table 55 Germany: Market Size, By Technology, 2014-2021 (USD Million)
Table 56 Germany: Market Size, By Product and Service, 2014-2021 (USD Million)
Table 57 Germany: Market Size, By End User, 2014-2021 (USD Million)
Table 58 France: Market Size, By Technology, 2014-2021 (USD Million)
Table 59 France: Market Size, By Product and Service, 2014-2021 (USD Million)
Table 60 France: Market Size, By End User, 2014-2021 (USD Million)
Table 61 U.K.: Market Size, By Technology, 2014-2021 (USD Million)
Table 62 U.K.: Market Size, By Product and Service, 2014-2021 (USD Million)
Table 63 U.K.: Market Size, By End User, 2014-2021 (USD Million)
Table 64 Italy: Market Size, By Technology, 2014-2021 (USD Million)
Table 65 Italy: Market Size, By Product and Service, 2014-2021 (USD Million)
Table 66 Italy: Market Size, By End User, 2014-2021 (USD Million)
Table 67 Spain: Market Size, By Technology, 2014-2021 (USD Million)
Table 68 Spain: Market Size, By Product and Service, 2014-2021 (USD Million)
Table 69 Spain: Blood Screening Market Size, By End User, 2014-2021 (USD Million)
Table 70 RoE: Blood Screening Market Size, By Technology, 2014-2021 (USD Million)
Table 71 RoE: Blood Screening Market Size, By Product and Service, 2014-2021 (USD Million)
Table 72 RoE: Blood Screening Market Size, By End User, 2014-2021 (USD Million)
Table 73 Asia: Blood Screening Market Size, By Country, 2014-2021 (USD Million)
Table 74 Asia: Blood Screening Market Size, By Technology, 2014-2021 (USD Million)
Table 75 Asia: Blood Screening Market Size, By Product and Service, 2014-2021 (USD Million)
Table 76 Asia: Blood Screening Market Size, By End User, 2014-2021 (USD Million)
Table 77 Japan: Blood Screening Market Size, By Technology, 2014-2021 (USD Million)
Table 78 Japan: Blood Screening Market Size, By Product and Service, 2014-2021 (USD Million)
Table 79 Japan: Blood Screening Market Size, By End User, 2014-2021 (USD Million)
Table 80 China: Blood Screening Market Size, By Technology, 2014-2021 (USD Million)
Table 81 China: Blood Screening Market Size, By Product and Service, 2014-2021 (USD Million)
Table 82 China: Blood Screening Market Size, By End User, 2014-2021 (USD Million)
Table 83 India: Blood Screening Market Size, By Technology, 2014-2021 (USD Million)
Table 84 India: Blood Screening Market Size, By Product and Service, 2014-2021 (USD Million)
Table 85 India: Blood Screening Market Size, By End User, 2014-2021 (USD Million)
Table 86 RoA: Blood Screening Market Size, By Technology, 2014-2021 (USD Million)
Table 87 RoA: Blood Screening Market Size, By Product and Service, 2014-2021 (USD Million)
Table 88 RoA: Blood Screening Market Size, By End User, 2014-2021 (USD Million)
Table 89 RoW: Blood Screening Market Size, By Technology, 2014-2021 (USD Million)
Table 90 RoW: Blood Screening Market Size, By Product and Service, 2014-2021 (USD Million)
Table 91 RoW: Blood Screening Market Size, By End User, 2014-2021 (USD Million)
Table 92 Product Launches, 2013-2016
Table 93 Regulatory Approvals, 2013-2016
Table 94 Agreements, 2013-2016
Table 95 Partnerships, 2013-2016
Table 96 Acquisitions, 2013-2016
Table 97 Expansions, 2013-2016

List of Figures (39 Figures)
Figure 1 Research Design
Figure 2 Blood Screening Market: Bottom-Up Approach
Figure 3 Top-Down Approach
Figure 4 Data Triangulation Methodology
Figure 5 Blood Screening Market Size, By Product and Service, 2016 vs 2021 (USD Billion)
Figure 6 Blood Screening Market Size, By Technology, 2016 vs 2021 (USD Billion)
Figure 7 Blood Screening Market Size, By End User, 2016 vs 2021 (USD Billion)
Figure 8 North America Accounted for the Highest Share of the Blood Screening Market in 2016
Figure 9 Blood Screening Market to Showcase Lucrative Growth Opportunities in the Forecast Period
Figure 10 NAT Segment to Account for the Largest Market Share in 2016
Figure 11 Asia to Grow at the Highest Rate During the Forecast Period
Figure 12 Global Incidences of Cancer
Figure 13 NAT Testing Will Continue to Dominate the Market During the Forecast Period
Figure 14 Reagents & Kits Segment to Hold Largest Share of the Market During the Forecast Period
Figure 15 Blood Banks Segment Will Continue to Dominate the Blood Screening Market During the Forecast Period
Figure 16 Emerging Markets Offer Significant Growth Opportunities
Figure 17 Asian Blood Screening Market Expected to Grow at the Highest CAGR During the Forecast Period
Figure 18 North America: Market Snapshot
Figure 19 Reagents and Kits Segment to Hold Largest Share in the U.S. Market
Figure 20 Europe: Market Snapshot
Figure 21 Germany: Blood Screening Market, By Product and Service
Figure 22 Asia: Blood Screening Market Snapshot
Figure 23 ELISA Segment to Grow at the Highest CAGR in the Japanese Market During 2016-2021
Figure 24 Blood Banks End-User Segment Will Continue to Dominate the Indian Blood Screening Market Till 2021
Figure 25 RoW: Market Snapshot
Figure 26 Product Launches, the Key Strategy Adopted By Leading Players
Figure 27 NAT Blood Screening Market Share Analysis, By Key Player, 2015
Figure 28 Blood Screening Market Share Analysis, By Key Player, 2015
Figure 29 Battle for Market Share: Product Launches, Partnerships and Agreements, the Key Growth Strategies Adopted Between 2014 & 2016
Figure 30 Product Benchmarking of the Top 5 Players
Figure 31 Grifols: Company Snapshot
Figure 32 F. Hoffmann-La Roche Ltd: Company Snapshot
Figure 33 Abbott Laboratories: Company Snapshot
Figure 34 Biomérieux: Company Snapshot
Figure 35 Bio-Rad Laboratories, Inc.: Company Snapshot
Figure 36 Siemens AG: Company Snapshot
Figure 37 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 38 Danaher Corporation: Company Snapshot
Figure 39 Becton, Dickinson and Company: Company Snapshot

発刊日

2016/12

体裁

PDF / 139ページ

販売価格

5,650USD

発行

MarketsandMarkets

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

診断・検査薬 / 医療器具・機器

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE